Skip to main content
Caplight Logo









Space LiinTech

Space LiinTech

Private
DaejeonHealthcare & Life Scienceshttps://spaceliintech.com/

Last Round

Series B

Extension

May 1, 2026

Est. Valuation

$22.3M

Total Funding Raised

$9.12M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Space LiinTech is a biotechnology company that operates a space-based biopharmaceutical platform for research and production in microgravity environments.

Sector

Healthcare & Life Sciences

Verticals

Space Technology, Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

space biopharmamicrogravity researchspace CROspace CDMOprotein crystallizationin-orbit manufacturingdrug discoveryCubeSatspace medicinebiomanufacturingpayload systemsdrop towerin-orbit laborbital researchspace economy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Space LiinTech Comparables

Compare Space LiinTech with similar companies based on industry and business-model similarity.

Space LiinTech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Frontier Space Technologies
87%
BioOrbit
84%
SpacePharma
83%

Space LiinTech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionMay 1, 2026
Series BJul 10, 2025
GrantJan 1, 2025
Series AApr 11, 2024
SeedApr 1, 2023

Space LiinTech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 59% MoM.

  • May 16, 2026

    Grew 27% QoQ, from 11 to 14 employees.

Recent news

Latest coverage and updates

  • is_developingJul 12, 2026

    Spaceliintech is developing autonomous microgravity pharmaceutical research and manufacturing platform on Jul 8th '26.

Space LiinTech Filings

Explore SEC and related filing metadata, where available.

Space LiinTech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Space LiinTech's valuation, stock price, and market status.

Is Space LiinTech a public or private company?

Space LiinTech is a private company.

What is the current stock price of Space LiinTech?

Space LiinTech is a private company with no public stock price. No recent secondary market data is available.

How much is Space LiinTech worth (valuation)?

Space LiinTech's valuation is estimated at $10.9M based on funding round data.

Can I buy Space LiinTech stock?

Space LiinTech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Space LiinTech's last funding round?

Space LiinTech's most recent funding round was Series B on April 11, 2024.

Who are the main investors in Space LiinTech?

Key investors in Space LiinTech include Company K Partners, Woori Venture Partners Co., Ltd., Daol Investment.

Will Space LiinTech IPO soon?

No public IPO plans have been announced for Space LiinTech.

How can I track Space LiinTech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Space LiinTech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDaejeon
Employee Range14
Year Founded2021
Last FundingMay 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?